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 Abbreviations 31 
C, control diet; C-C, offspring exposed to a control diet before weaning and given 32 
saline injections; C-N, offspring exposed to a control diet before weaning and given 33 
naloxone injections; D1, dopamine receptor 1 ; D2, dopamine receptor 2 ; DAT, 34 
dopamine active transporter ; JF, junk food diet; JF-C, offspring exposed to a junk 35 
food diet before weaning and given saline injections; JF-N, offspring exposed to a 36 
junk food diet before weaning and given naloxone injections; NAc, nucleus 37 
accumbens; TH, tyrosine hydroxylase ; VTA, ventral tegmental area.  38 





We have previously reported that the opioid receptor blocker, naloxone, is less effective at 41 
reducing palatable food intake in offspring exposed to a maternal cafeteria diet during the 42 
perinatal period, implicating a desensitization of the central opioid pathway in the 43 
programming of food preferences. The present study aimed to investigate the effect of a 44 
maternal cafeteria diet and naloxone treatment on the development of the mesolimbic reward 45 
pathway and food choices in adulthood.  We measured mRNA expression of key components 46 
of the reward pathway (mu-opioid receptor, proenkephalin, tyrosine hydroxlase, D1 and D2 47 
receptors and the dopamine active transporter (DAT)) in the nucleus accumbens (NAc) and 48 
ventral tegmental area (VTA) of the offspring of control and cafeteria fed (JF) dams at 49 
weaning and after a 10-day naloxone treatment post-weaning; and determined food 50 
preferences in adulthood in the remaining offspring.  Naloxone treatment decreased the 51 
expression of DAT by 8.2 fold in female control offspring but increased it by 4.3 fold in 52 
female offspring of JF dams relative to the saline-injected reference groups. Proenkephalin 53 
mRNA expression was higher in the NAc of female JF offspring compared to controls, 54 
independent of naloxone treatment (P<0.05). There was no effect of naloxone treatment on 55 
food preferences in adulthood in either control or JF offspring. These data indicate that 56 
prenatal exposure to a cafeteria diet alters the impact of opioid signaling blockade in the early 57 
post-weaning period on gene expression in the central reward pathway in a sex specific 58 
manner, but that these changes in gene expression do not appear to have any persistent impact 59 
on food preferences in adulthood. 60 








1. Introduction 66 
The increased consumption of  junk foods is a major contributing factor to the rise in obesity 67 
prevalence [1, 2]. The term ‘junk food’ can be used to describe any food that is high in fat, 68 
sugar and salt, low in protein and otherwise energy dense and nutrient poor [3]. The ready 69 
availability of ‘junk foods’ in modern society makes it important to understand why some 70 
people have a greater tendency to over-consume these types of food than others. In this 71 
context, it is significant that data from both human and animal studies have shown that food 72 
preferences can be established very early in life, and that excessive maternal intake of junk 73 
foods during pregnancy and lactation is associated with an increased preference for fat and 74 
sugar in juvenile and adult offspring [4, 5].  75 
More recently, attempts have been made to understand the mechanisms which contribute to 76 
the programming of food preferences, with a particular focus on the impact of perinatal ‘junk 77 
food’ exposure on the mesolimbic reward system. We and others have demonstrated that 78 
maternal consumption of high-fat and/or cafeteria diets during pregnancy and lactation 79 
induces permanent alterations in the structure and function of this system in juvenile and adult 80 
offspring [4, 6, 7]. We have previously shown that the mRNA expression of the mu-opioid 81 
receptor in the central reward pathway at weaning is reduced by perinatal exposure to a ‘junk 82 
food’ diet, and that this was associated with a reduced sensitivity to the effect of the opioid 83 
antagonist, naloxone, in reducing fat intake after weaning [8]. These findings led us to 84 
hypothesize that the opioid signaling pathway plays a critical role in the early programming of 85 
food preferences, and that exposure to excess endogenous opioids during the perinatal period  86 
as a result of maternal junk food consumption [9, 10]  alters the development of the opioid 87 
signaling pathway in the offspring, resulting in persistent effects on the function of the reward 88 
system.  89 
In the current study, we sought to extend our previous findings by investigating the impact of 90 
naloxone administration for a 10 day period after weaning on gene expression of key 91 




effect opioid receptor blockade on the mRNA expression of mu-opioid receptor and the 93 
endogenous opioid proenkephalin as well as elements of the dopamine pathway including 94 
tyrosine hydroxlase (TH), dopamine receptors 1 and 2 and the dopamine active transporter 95 
(DAT), all of which have been previously implicated in the regulation of palatable food 96 
intake[11-17]. We hypothesized that opioid receptor blockade would ameliorate the changes 97 
in gene expression in the dopamine and opioid pathways we have previously reported in 98 
offspring exposed to cafeteria diets during the perinatal period [4, 8]. We also aimed to 99 
investigate the hypothesis that opioid antagonist treatment in the immediate post-weaning 100 
period would have persistent effects on food preferences in the adult offspring, independent of 101 
perinatal dietary exposure. 102 
2. Methods 103 
2.1 Animals and feeding 104 
This study was approved by the Animal Ethics committee of the University of Adelaide. 105 
Details of the experimental procedure have been published previously [8]. Briefly, 37 female 106 
and 4 male Albino Wistar rats were allowed to acclimatize to animal housing facility for at 107 
least 1 week before the commencement of the dietary intervention. Female rats were divided 108 
into either the control (C, n=18) or junk food (JF, n=19) group, such that the average weight 109 
of the animals at the start of the experiment was not different between treatments. The C 110 
group received a standard rodent feed (Specialty Feeds, Glen Forrest, WA, Australia), while 111 
the JF group received a cafeteria diet that included peanut butter, hazelnut spread, savory 112 
snacks, chocolate biscuits, sweetened cereal and a lard and chow mix. Detailed nutritional 113 
information on this diet has been published previously [4]. The female rats were provided 114 
with their respective diets for two weeks prior to mating and throughout pregnancy and 115 
lactation. 116 
Females were mated with one of 4 proven males (the same males were used for both groups), 117 




litters were culled to 8 pups (4 male, 4 female where possible) 24 hours after birth. Pups were 119 
housed with their mothers and weighed every second day until weaning at postnatal day 21. 120 
The offspring of C and JF dams are referred as C and JF offspring respectively.  121 
2.2 Naloxone treatment 122 
At weaning, pups were either killed for gene expression analysis or housed with a same sex 123 
littermate and administered the opioid antagonist naloxone or saline (vehicle). Details of this 124 
procedure have been published previously [8]. Briefly, pups were randomly assigned to 125 
receive daily intraperitoneal injection of either naloxone, (5mg/kg, naloxone hydrochloride 126 
dihydrate, Sigma Aldrich, St Louis, MO USA) or an equivalent volume of saline (vehicle) 30 127 
minutes before the onset of the dark cycle for 10 days.  Naloxone at this dose has been 128 
previously reported to acutely suppress food intake in pre-weaning rat pups [18] and we 129 
confirmed in a pilot dose-response study that this dose was the most effective in reducing 130 
intake of the cafeteria diet in the immediate post-injection period, without any adverse effects 131 
on pup growth/development.  All rats were weighed immediately prior to injection to ensure 132 
accurate dosage. All offspring were given free access to both the control and cafeteria diet 133 
throughout the injection period to allow the determination of food preferences (results 134 
previously published [8]). This generated four groups of offspring, offspring of C dams given 135 
saline (C-C, n=15 male, 16 female), offspring of C dams given naloxone (C-N, n=16 male, 16 136 
female), offspring of JF dams given saline (JF-C, n=18 male, 14 female) and offspring of JF 137 
dams give naloxone (JF-N, n=17 male, 14 female). 138 
2.3 Determination of gene expression in the NAc and VTA at 3 weeks 139 
 Pups not designated to receive the naloxone/saline treatment were killed at weaning and the 140 
whole brain was removed (C, n=10 male, 8 female and JF, n=9 male, 8 female). The nucleus 141 
accumbens including both shell and core regions (NAc) and  the ventral tegmental area 142 
(VTA) were isolated and stored as described previously [4]. Total mRNA was extracted using 143 




RNeasy Mini kit (Qiagen Australia, Doncaster, Vic, Australia) and cDNA synthesized using 145 
Superscript III reverse transcriptase (Invitrogen Australia) and random hexamers.  146 
Quantitative real-time RT-PCR was performed on the LightCycler® 480 Real Time PCR 147 
System (Roche Diagnostics, Mannheim, Germany) using the SYBR green system. Primer 148 
sequences for the mu-opioid receptor and the dopamine related genes: tyrosine hydroxylase 149 
(TH),  dopamine receptor 1 (D1), dopamine receptor 2 (D2) as well as the dopamine active 150 
transporter (DAT) have been previously validated and published [4]. mRNA expression of the 151 
reference gene β-actin was measured using the β-actin Quantitect primer assay (Qiagen 152 
Australia, Doncaster, Vic, Australia). The amplification efficiency of the primers was 0.997-153 
0.999 and 2 quality controls were added to each plate to verify interplate consistency. The 154 
expression of target gene mRNA relative to β-actin expression was calculated using Q-gene 155 
qRT-PCR analysis software. 156 
2.4 Determination of gene expression in the NAc and VTA at 3 weeks and 10 days 157 
At the conclusion of the 10 day injection period during which both the standard rodent feed 158 
and cafeteria diet were available, a subset of offspring (C-C, n= 8 male, 8 female; C-N, n=8 159 
male, 8 female; JF-C, n= 9 male, 8 female; JF-N, n=9 male, 8 female) were killed and brain 160 
tissue collected. RNA was isolated from the VTA and NAc and cDNA generated as described 161 
for the 3wk time point.  Quantitative real time PCR was performed using the SYBR green 162 
system on the Applied Biosystems ViiA 7 Real-Time PCR machine (Applied Biosystems, 163 
Foster City, CA, USA). Target genes were the same as at 3 weeks with the addition of the 164 
endogenous opioid proenkephalin. The primer sequences have been previously published [4, 165 
19] and the proenkephalin primers were validated for use in our laboratory prior to beginning 166 
the experiment. The expression of target genes was quantified relative to three housekeeper 167 
genes: β-actin, cyclophilin and GAPDH, using the Applied Biosystems Data Assist software 168 
(Applied biosystems, Foster City, CA, USA). This software allows expression of each target 169 




quality controls as well as a negative RT control were used on each 384-well plate to ensure 171 
inter-plate consistency and melt curves were obtained at the end of each run. 172 
2.5 Determination of food preferences 173 
Following naloxone/saline treatment, remaining offspring (not used in gene expression 174 
analysis) were placed on the standard rodent feed until 10 weeks of age. Offspring (C-C, n= 7 175 
male, 8 female; C-N, n=8 male, 8 female; JF-C, n= 9 male, 6 female; JF-N, n=8 male, 6 176 
female) were then given access to the both the standard rodent feed and the cafeteria diet for a 177 
further two weeks until 12 weeks age. The amount of standard rodent feed and each 178 
component of the cafeteria diet consumed were assessed every two days and macronutrient 179 
preference calculated based on the nutritional composition of each food type. Body weight of 180 
the offspring was recorded weekly from weaning.  181 
2.6 Postmortem 182 
At 3 weeks, 3 weeks +10 days and 12 weeks of age, one male and one female pup from each 183 
litter was killed for the determination of body fat mass. The rats were not fasted prior to 184 
postmortem and all postmortems were conducted in light phase between 8-10 AM. All 185 
animals were weighed immediately prior to being killed with an overdose of CO2. All internal 186 
organs were weighed and individual fat depots including retroperitoneal fat, omental fat, 187 
gonadal fat, interscapular fat and subcutaneous fat were isolated to determine the weight of 188 
each depot as well as total fat mass. All fat depots were snap frozen in liquid nitrogen and 189 
stored at -80°C for future molecular analyses. Blood samples were collected by cardiac 190 
puncture into heparinized tubes, and blood was centrifuged at 3,500g, 4˚C for 15 minutes and 191 
plasma stored at -20˚C for subsequent analysis of hormone and metabolite concentrations. 192 
2.7 Determination of hormone and metabolite concentrations 193 
Plasma concentrations of glucose and non-esterified fatty acids (NEFA) were analysed using 194 




NEFA C kit (Wako Pure Chemical Industries Ltd, Osaka, Japan), respectively. Assays were 196 
performed using Konelab 20 (Thermo Scientific, Vantaa, Finland). Plasma leptin and insulin 197 
concentrations were measured by immunoassay using the Crystal Chem Rat Leptin ELISA kit 198 
(Crystal Chem Inc, Downers Grove, IL, USA) and the ALPCO Insulin (Rat) Ultrasensitive 199 
ELISA kit (ALPCO Diagnostics, Salem, NH, USA). All assays were conducted in accordance 200 
with manufacturer’s instructions and intra- and inter-assay coefficients of variation were 201 
<10%. 202 
2.8 Statistical Analysis 203 
Analysis of gene expression, plasma hormones, food preference and fat mass was conducted 204 
using a two-way ANOVA with maternal diet and naloxone/saline treatment as factors. The 205 
two-way ANOVA was performed using SPSS statistics 18.0 software (SPSS Inc., Chicago, 206 
IL, USA). Offspring body weight gain and food intake over time was analysed by two-way 207 
repeated measures ANOVA, which was performed on Stata 11 software (StataCorp., TX, 208 
USA). Male and female offspring were analysed separately for all measures to provide clarity 209 
in presentation, as three-way ANOVA analysis using sex as an additional factor revealed a 210 
significant interaction between sex and treatment for the majority of outcomes measured. All 211 
data are presented as mean±SEM with a P value of <0.05 considered statistically significant. 212 
3. Results 213 
 3.1 Effect of maternal diet on birth outcomes 214 
Birth outcomes including birth weight of these offspring has been previously published [8]. 215 
Both male (C= 53.7±1.7g, JF=45.0±1.1g, P<0.01) and female offspring (C=52.3±1.6g, 216 







3.2 Effect of maternal diet on target gene expression in the VTA and NAc at weaning 221 
As published previously, mRNA expression of the mu-opioid receptor at weaning was lower 222 
in the VTA of both male and female JF offspring, and higher in the NAc of male, but not 223 
female, JF offspring compared to C offspring [8]. There was no effect of perinatal diet 224 
exposure on DAT expression in the VTA (Table 1), whilst in the NAc DAT expression was 225 
lower in the offspring of JF dams compared to controls in both males and females (P<0.05, 226 
Table 1). There was no difference in the mRNA expression of TH or the D1 and D2 dopamine 227 
receptors in either brain region between the control and JF offspring in either males or 228 
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Female 
       Parameter 
C 
     




TH 480.0±100.0 410.0 ±100.0 
 
530.0±100.0 610.0±200.0 
D1 0.7 ±0.2 0.7 ±0.2 
 
0.7 ±0.3 0.3 ±0.1 
D2 100.0±20.0 100.0±20.0 
 
100.0±20.0 140.0±30.0 
 DAT 344.5±70.0 432.9±61.8 
 
441.9±79.0 621.2±125.5 
       
NAc 
TH 0.5 ±0.1 0.6  ± 0.1 
 
0.6 ± 0.2 0.4 ±0.1 
D1 30.0±5.0 30.0 ± 4.2 
 
40.0±7.5 40.0 ±7.4 
D2 70.0 ±9.4 70.0 ±10.0 
 
50.0 ±8.5 70.0 ±7.8 
 DAT 0.10±0.04 0.04±0.01* 
 
0.20±0.08 0.05±0.02* 
Table 1. Mean normalized gene expression of dopamine related genes in the VTA and NAc of the male 
and female offspring of C and JF dams at 3 weeks of age 
Values expressed as mean ± SEM, n=8-10 for all groups. * indicates significant differences between 




3.3 Effect of naloxone treatment on target gene expression in the VTA and NAc in control and 231 
JF offspring 232 
3.3.1 Mu-opioid receptor and proenkephalin  233 
There was no effect of naloxone treatment on mu-opioid receptor expression in the VTA of 234 
either male or female C or JF offspring (Fig. 1A). The mRNA expression of the mu-opioid 235 
receptor in the NAc was higher in male JF offspring compared to controls (P<0.05), and also 236 
tended (P=0.07) to be higher in female JF offspring, independent of whether they received 237 
naloxone or saline (Fig. 1B).  238 
The effect of naloxone treatment during the post-weaning period on mRNA expression of the 239 
endogenous opioid, proenkephalin, in the VTA of male offspring was influenced by perinatal 240 
diet, such that mRNA expression was reduced by naloxone treatment only in those offspring 241 
exposed to a JF diet before weaning (P<0.05, Fig 1C). There was no effect of either perinatal 242 
diet or naloxone treatment on proenkephalin mRNA expression in the NAc of male offspring 243 
(Fig. 1C). In females, there was no effect of either naloxone treatment or perinatal diet on 244 
proenkephalin mRNA expression in the VTA. Proenkephalin expression in the NAc, 245 
however, was significantly higher in female JF offspring compared to control offspring 246 
independent of naloxone treatment (P<0.05, Fig. 1D).  247 
3.3.2 DAT, TH and the D1 and D2 dopamine receptors 248 
In female offspring, the effects of naloxone treatment on DAT expression in both the VTA 249 
and NAc was dependent on perinatal dietary exposure; such that DAT expression was 250 
decreased by naloxone treatment in C offspring but increased by naloxone treatment in JF 251 
offspring in both brain regions (P<0.05, Fig. 1E, F). In male offspring, naloxone treatment 252 
decreased DAT expression in the NAc of both C and JF offspring (P<0.05, Fig. 1F), but there 253 
was no effect of either perinatal dietary exposure or naloxone treatment on DAT mRNA 254 






































































































































 Figure 1 Expression of the mu-opioid receptor, proenkephalin (Penk) and DAT in the VTA 256 
(A, C, E) and NAc (B,D, F) in the male and female offspring of control dams given saline (C-257 
C, open bars) or naloxone (C-N, closed bars) and offspring of junk food dams given saline 258 
(JF-C, striped bars) or naloxone (JF-N, grey shaded bars) at 3 weeks +10 days. Results 259 
presented as mean±SEM.  n=8-9 pups for all groups. Different letters above the bars denote 260 
significant differences between groups P<0.05. * indicates a significant interaction between 261 







































































































































































































































There was no effect of either perinatal diet or naloxone treatment on TH, D1 or D2 mRNA 264 
expression in male offspring in either the NAc or VTA.  In contrast, TH and D2 mRNA 265 
expression was decreased in the VTA of female JF offspring compared to C offspring, 266 
independent of naloxone treatment (Table 2). Naloxone treatment also reduced D1 receptor 267 
expression in the VTA, but not NAc, of female JF offspring. In contrast D1 and D2 receptor 268 
expression in the NAc was decreased by naloxone treatment in C offspring (Table 2). 269 
3.4 Effect of maternal diet and naloxone on plasma hormone and metabolite concentrations at 270 
3 weeks +10 days 271 
There was no effect of either perinatal diet or naloxone treatment on plasma concentrations of 272 
glucose, NEFA, insulin or leptin at 10 days postweaning in either male or female offspring 273 
(Table 3).  274 
Effect of maternal diet and naloxone treatment on offspring growth and food intake 275 
From weaning (day 21) until 12 weeks of age (day 90) both male (P<0.05, Fig. 2A) and 276 
female (P<0.05, Fig. 2B) JF offspring were significantly lighter than C offspring.  There was 277 
no effect of naloxone treatment on body weight at any time point during the experiment in 278 
either C or JF offspring 279 
As previously reported, during the 10 day naloxone treatment post-weaning, when all 280 
offspring had free access to both the cafeteria diet and standard laboratory chow female, but 281 
not male, JF offspring consumed more fat and energy than their control counterparts [8].  282 
From the end of the 10 day naloxone treatment (3weeks + 10 days of age) until 10 weeks of 283 
age all offspring were fed standard laboratory chow. For the first 4 weeks on the chow diet 284 
both male and female offspring of JF dams had significantly higher food intake than C 285 
offspring independent of whether they had been treated with saline or naloxone (P<0.05, Fig, 286 
4A,B). An interaction was present between perinatal diet and postnatal week, such that the 287 




In male offspring only, there were no longer any significant differences in food intake 289 
between C and JF offspring by the fifth week on the chow diet (10 postnatal weeks) (Fig. 3A). 290 
Chow intake in female offspring remained significantly higher than C offspring throughout 291 
this period (P<0.05, Fig. 3B). 292 
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   Male 
 
Female 
                 
Parameter  C-C C-N JF-C JF-N 
 
C-C C-N JF-C JF-N 
 
VTA 









D1  1.3±0.3 2.1±0.6 1.5±0.2 1.4±0.4  0.6±0.1 0.6±0.2 0.9±0.1 0.5±0.1
*
 









            
NAc 
TH  0.5±0.1 0.5±0.1 0.4±0.1 0.5±0.1  0.6 ±0.1 0.8 ±0.1 0.5 ±0.1 0.5 ±0.1 
D1  30.0±9.1 30.0±5.3 40.0±8.8 50.0±10.0  30.0 ±3.8 10.0 ±1.8
*
 30.0 ±3.8 30.0±4.0 
D2  50.0±10.0 90.0±20.0 60.0±10.0 50.0±10.0  120.0±10.0 50.0 ±7.6
*
 70.0 ±20.0 80.0 ±8.2 
Table 2. Mean normalized gene expression of dopamine related genes in the VTA and NAc of male and 
female offspring of C and JF dams treated with saline or naloxone at 3weeks and10 days 
Values expressed as mean±SEM, n= 8-9 for all groups. Values have been multiplied by one thousand for ease 
of presentation. Different superscript letters denote significant differences between groups within each sex  * 











 C-C C-N JF-C JF-N 
 
C-C C-N JF-C JF-N 
Glucose 
(mM) 
 7.5±0.52 7.6±0.51 7.9±0.34 8.2±0.42 
 
9.1±1.17 7.8±0.24 7.6±0.48 8.9±1.13 
NEFA 
(meq/ml) 
 0.3±0.03 0.3±0.03 0.3±0.04 0.3±0.04 
 
0.4±0.06 0.3±0.05 0.4±0.05 0.3±0.08 
Insulin 
(µU/ml) 
 0.4±0.10 0.4±0.06 0.4±0.11 0.6±0.13 
 
0.3±0.10 0.7±0.17 0.6±0.16 0.7±0.20 
Leptin 
(µg/L) 
 9.9±0.93 12.5±1.16 9.4±1.12 10.8±0.65 
 
11.1±0.75 11.7±1.27 10.9±0.90 10.2±1.44 
Table 3. Plasma concentrations of glucose, NEFA, insulin and leptin in male and female offspring of C and JF 
dams treated with either saline or naloxone at 3wk+10days 




Figure 2  Body weight of male (A) and female offspring of control dams given saline (C-C, 297 
open bars) or naloxone (C-N, closed bars) and offspring of junk food dams given saline (JF-298 
C, striped bars) or naloxone (JF-N, grey shaded bars) from postnatal week 3 to postnatal week 299 
12. n=6-8 animals for all groups, results presented as mean±SEM. * indicates a significant 300 
effect of maternal diet on offspring body weight P<0.05 301 
  302 
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Figure 3  Intake of total energy from standard laboratory chow of male (A) and female (B) 303 
offspring of control dams given saline (C-C, open bars) or naloxone (C-N, closed bars) and 304 
offspring of junk food dams given saline (JF-C, striped bars) or naloxone (JF-N, grey shaded 305 
bars) from postnatal week 6 to postnatal week 10. Results presented as mean±SEM, n=6-8 306 
animals for all groups. * indicates a significant effect of maternal diet on offspring energy 307 
intake P<0. 05. 308 
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3.5 Effect of maternal diet and naloxone treatment on offspring food preference and body 310 
composition 311 
When all offspring were provided with free access to both the control and cafeteria diet for 312 
two weeks from 10-12 weeks of age, there was no difference in food intake between groups in 313 
either males or females. Thus, neither perinatal diet nor naloxone treatment had any effect on 314 
the intake of fat, carbohydrate, protein or total energy during this period (Table 4). There was 315 
also no difference between groups in the intake of any individual component of the cafeteria 316 
diet or the control diet in either males or females (data not shown). 317 
At 12 weeks of age, there was no significant differences in the percentage of total body fat 318 
mass between C and JF offspring nor any effect of naloxone treatment in either males (C-C 319 
16.5±0.95%, C-N 16.0±0.64%, JF-C 14.2±0.72%, JF-N 14.8±0.57%) or females (C-C 320 
19.3±0.10%, C-N 19.0±0.78%, JF-C 18.5±0.13%, JF-N 18.7±0.15%). 321 










 C-C C-N JF-C JF-N 
 
C-C C-N JF-C JF-N 
Fat 
(g/kg/day) 
 16.5±0.47 14.9±1.29 17.1±0.66 16.6±0.55 
 
19.2±0.48 18.4±1.06 19.6±0.62 20.3±0.72 
Carbohydrate 
(g/kg/day) 
 37.9±0.76 35.4±2.08 38.8±1.69 39.9±1.30 
 
43.7±1.20 43.9±1.91 44.6±3.00 44.8±2.17 
Protein 
(g/kg/day) 
 9.3±0.32 8.5±0.53 9.0±0.35 9.0±0.36 
 
9.6±0.21 9.8±0.30 9.2±0.50 9.5±0.43 
Energy 
(kJ/kg/day) 
 1411.0±18.72 1289.2±81.97 1415.1±48.40 1422.1±35.39 
 
1578.9±21.14 1564.2±56.10 1601.5±72.11 1637.8±68.69 
Table 4. Average daily macronutrient intake of control and junk food offspring treated with either 
saline or naloxone, when given access to both the control and JF diet from 10-12 weeks of age  




4. Discussion  324 
This study has shown that administration of the opioid antagonist naloxone for 10 days after 325 
weaning alters the gene expression of key components of the opioid and dopamine signaling 326 
pathways in the mesolimbic reward system in a sex-specific manner. Importantly, the effects 327 
of naloxone treatment on a number of these genes were dependent on whether pups had been 328 
exposed to a cafeteria (‘junk food’) diet during the perinatal period. The differences in gene 329 
expression at the end of the period of naloxone treatment were not, however, associated with 330 
altered food preferences in adulthood in either C or JF offspring. Thus, perinatal junk food 331 
exposure alters the short-term response of the reward pathway to opioid receptor blockade in 332 
the immediate post-weaning period, but opioid receptor blockade during this time does not 333 
appear to cause persistent alterations in food preferences, independent of the perinatal diet.  334 
4.1 Maternal JF consumption and naloxone treatment for 10 days postweaning can alter gene 335 
expression in the reward pathway of offspring 336 
In the present study, we found no difference in expression of the mu-opioid receptor in the 337 
VTA between C and JF offspring at 10 days after weaning, independent of whether the 338 
offspring had been treated with naloxone or saline during this period. This is different to the 339 
situation at weaning, at which time mu-opioid receptor expression in the VTA is lower in JF 340 
offspring than controls [8]. In interpreting these findings, it is important to note that all 341 
offspring, independent of their perinatal nutrition, were provided with free access to the 342 
cafeteria diet during the 10 day period of naloxone/saline treatment. One possible explanation, 343 
therefore, is that a 10 day period of junk food exposure after weaning was sufficient to induce 344 
a down-regulation of mu-opioid receptor expression to the same level as in offspring who 345 
were also exposed to junk food during the perinatal period. In males, mu-opioid receptor 346 
expression in the NAc was increased in JF offspring both at weaning [8] and after the 10 day 347 
naloxone/saline treatment. Increases in expression of the mu-opioid receptor in the NAc have 348 




consequence of perinatal exposure to a palatable diet [6]. These results also highlight that the 350 
response to perinatal dietary exposures varies between specific brain regions. It is possible 351 
that the increased mu-opioid expression in the NAc is a result of chronic exposure to the 352 
cafeteria diet during the development of the reward pathway, since chronic sugar 353 
consumption has been previously reported to increase mu-opioid receptor expression in this 354 
brain region in adult rats [20].  355 
Interestingly, we found no effect of naloxone treatment on mu-opioid expression in either the 356 
NAc or VTA. This was unexpected given that naloxone treatment in rodents prior to weaning 357 
has previously been shown to increase mu-opioid receptor levels in the striatum [21, 22]. 358 
However, in these prior studies naloxone treatment was given from birth and receptor levels 359 
were measured using radio-labelled binding analysis which may have contributed to the 360 
incongruent results. It is also possible, however, that the availability of the cafeteria diet 361 
during the period of naloxone exposure, and the associated stimulation of endogenous opioid 362 
production, was sufficient to counteract the effect of opioid receptor blockade, thus resulting 363 
in a maintenance of receptor expression.  364 
While there were no differences in the expression of the mu-opioid receptor in the NAc 365 
between control and JF offspring in females, mRNA expression of the endogenous opioid, 366 
proenkephalin, was increased in this brain region in female JF offspring, but was not affected 367 
by naloxone treatment. This is consistent with previous studies in which exposure to a high-368 
fat and/or high-sugar diet was reported to increase the release of endogenous opioids [9, 10]. 369 
It is possible that the higher proenkephalin expression in female JF offspring was a 370 
consequence of their higher fat intake in the 10 days post-weaning, since previous studies 371 
have reported positive associations between proenkephalin expression and fat consumption in 372 
adult rodents [23]. In male offspring, proenkephalin mRNA expression was reduced by 373 
naloxone treatment in offspring of JF dams, but not in offspring of control dams. Given that 374 
opioid receptor blockade is typically associated with a compensatory up regulation of 375 




subsequent response of the reward pathway to opioid receptor blockade, indicating a potential 377 
dysregulation of opioid signaling in these offspring.   378 
4.2 Female offspring more are more susceptible to the effects of maternal JF diet and 379 
naloxone treatment on the dopamine pathway  380 
The majority of the effects of perinatal junk food exposure and naloxone treatment on 381 
components of the dopamine signaling pathway were confined to female offspring, with the 382 
dopamine active transporter (DAT) being the only gene affected in both sexes. 383 
At weaning (prior to naloxone/saline treatment), DAT mRNA expression in the NAc was 384 
decreased in JF offspring compared to controls in both males and females. This result is 385 
consistent with previous studies in our laboratory, in which DAT mRNA expression at 6 386 
weeks of age was reduced in offspring exposed to a junk food diet during the perinatal period 387 
[4]. Since DAT is primarily responsible for the reuptake of dopamine from the synapse, and 388 
therefore terminating the dopamine signal, the lower DAT mRNA expression would be 389 
expected to result in increased dopamine signaling in the JF group. Interestingly, there were 390 
no longer any differences in DAT mRNA expression between the control and JF offspring at 391 
the end of the 10 day period of naloxone/saline treatment. Again, it is possible that exposure 392 
of the control offspring to junk food during this period could have resulted in reduced DAT 393 
mRNA expression. Interestingly, we saw no effect of either naloxone treatment or perinatal 394 
junk food exposure on DAT expression in the VTA, which is considered to be the main site of 395 
DAT activity [25, 26], however the significance of this finding remains unclear.  396 
We found that naloxone treatment reduced expression of DAT in the NAc of male offspring 397 
and in the VTA and NAc of female control offspring. Opioid receptor blockade has 398 
previously been shown to lower extracellular dopamine concentrations [27, 28], which may 399 
have elicited a compensatory downregulation of DAT in order to maintain dopamine 400 
signaling. Given that the naloxone treatment was applied at a time when the reward pathway 401 




increase in DAT mRNA expression, an alternate explanation may be that naloxone treatment 403 
inhibited this normal developmental process [29, 30]. Interestingly, in female JF offspring 404 
naloxone treatment increased DAT expression in both the VTA and NAc. This unexpected 405 
response to opioid receptor blockade may suggest a dysregulation of the reward pathway in 406 
these animals as a result of early life exposure to a junk food diet.  407 
In female offspring, but not in males, the expression of TH, D1 and D2 receptor mRNA was 408 
decreased by naloxone treatment in offspring exposed to the junk food diet during the 409 
perinatal period. Decreases in the expression of elements of the dopamine pathway have been 410 
previously associated with chronic cafeteria diet consumption [31, 32], whilst opioid 411 
antagonism has been shown to reduce extracellular dopamine levels [27, 33]. Different 412 
responses to exogenous opioids between sexes has also been widely reported in adults [34, 413 
35] and may be due to differences in levels of gonadal hormones between males and females, 414 
as estrogen is known to contribute to the regulation of the endogenous opioid system [36].  415 
4.3 Maternal JF consumption increases offspring chow intake during the juvenile period but 416 
did not affect palatable food intake in adult hood 417 
In the present study both male and female JF offspring exhibited an increased intake of 418 
standard rodent feed throughout the juvenile period (6-9 weeks) compared to controls.  This 419 
hyperphagia was most marked immediately after weaning, and became less pronounced with 420 
increasing postnatal age. The presence of hyperphagia in offspring exposed to an increased 421 
supply of fat and/or sugar during the perinatal period has been widely reported in previous 422 
studies  [37, 38], and is thought to be a consequence of programming of the central appetite 423 
regulating circuits [19].  424 
However, contrary to our hypothesis, we found no effect of opioid receptor blockade post-425 
weaning on food preferences in adulthood, independent of perinatal junk food exposure. Since 426 
the development of the reward circuitry extends into the fourth postnatal week in rodents [39, 427 




weaning was sufficient to program an increased preference for fat in adult control offspring 429 
equivalent to that induced by exposure to the cafeteria diet for the entire perinatal period. This 430 
is supported by data from a previous study, in which mice exposed to a palatable diet only 431 
during the fourth week of life were found to exhibit a greater preference for palatable foods as 432 
adults when compared to animals who had never been exposed to the palatable diet [41]. 433 
Furthermore, in our study, naloxone treatment was only administered at concentrations 434 
(5mg/kg) capable of reducing food intake for two hours post injection [42, 43]. The acute 435 
nature of the treatment may have limited any long term effects, since a previous study has 436 
identified changes in feeding behavior in juvenile rats which were treated with the opioid 437 
antagonist naltrexone (which is capable of reducing food intake for 6hrs post-injection [44])) 438 
from birth until weaning [45]. 439 
4.4 Conclusions 440 
We have shown for the first time that opioid receptor blockade induced by naloxone 441 
administration immediately post weaning alters gene expression in the reward pathway in a 442 
sex-specific manner, and that these effects are altered by perinatal junk food exposure. 443 
Contrary to our initial hypothesis, however, opioid receptor blockade in the fourth week of 444 
life did not have any long term effects on food preferences. These findings add to the growing 445 
body of literature suggesting that the developing opioid and dopamine pathways are 446 
susceptible to alteration by palatable food exposure during the perinatal period, but further 447 
studies are required in order to determine whether alterations to the opioid signaling system 448 
are the biological basis for the changes in food preferences observed. Better understanding the 449 
mechanisms behind the programming of food preferences will be vital if we hope to design 450 
interventions to prevent the cycle of obesity from mother to child from continuing.  451 
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